S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
NASDAQ:SBRA

Sabra Health Care REIT (SBRA) Stock Price, News & Analysis

$13.66
+0.23 (+1.71%)
(As of 04/19/2024 ET)
Today's Range
$13.40
$13.66
50-Day Range
$13.43
$14.77
52-Week Range
$10.30
$14.91
Volume
1.91 million shs
Average Volume
1.75 million shs
Market Capitalization
$3.16 billion
P/E Ratio
273.20
Dividend Yield
8.78%
Price Target
$15.54

Sabra Health Care REIT MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.60 Rating Score
Upside/​Downside
13.8% Upside
$15.54 Price Target
Short Interest
Healthy
4.83% of Shares Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
0.95mentions of Sabra Health Care REIT in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
5.11%
From $1.37 to $1.44 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.09 out of 5 stars

Finance Sector

669th out of 851 stocks

Real Estate Investment Trusts Industry

139th out of 180 stocks

SBRA stock logo

About Sabra Health Care REIT Stock (NASDAQ:SBRA)

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing - Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing - Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures. As of September 30, 2023, Sabra's real estate properties held for investment included 37,606 beds/units, spread across the United States and Canada.

SBRA Stock Price History

SBRA Stock News Headlines

“More countries ditch the US dollar”
Since March 2018, China started purchasing oil in gold-backed yuan. By December 2022, Foreign Minister Wang Yi stated that Chinese-Arab relations experienced a "historic improvement." after arab nations ditched the dollar to trade with China. On June 6, 2023 China told its banks to slash interest rates on US dollars.
6 Bargain Dividend Stocks To Buy
“More countries ditch the US dollar”
Since March 2018, China started purchasing oil in gold-backed yuan. By December 2022, Foreign Minister Wang Yi stated that Chinese-Arab relations experienced a "historic improvement." after arab nations ditched the dollar to trade with China. On June 6, 2023 China told its banks to slash interest rates on US dollars.
Q4 2023 Sabra Health Care REIT Inc Earnings Call
Sabra Health Care Q4 2023 Earnings Preview
Sabra Healthcare REIT Inc.
Sabra Health Care REIT: A Risk Worth Taking
Sabra Health Care REIT, Inc. (SBRA)
Sabra Health Care REIT Inc
Sabra Health Care declares $0.30 dividend
See More Headlines
Receive SBRA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sabra Health Care REIT and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/04/2022
Ex-Dividend for 2/29 Dividend
2/12/2024
Dividend Payable
2/29/2024
Today
4/21/2024
Next Earnings (Estimated)
5/01/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Finance
Industry
Real estate investment trusts
Sub-Industry
Specialized REITs
Current Symbol
NASDAQ:SBRA
CUSIP
78573L10
Employees
48
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$15.54
High Stock Price Target
$21.00
Low Stock Price Target
$12.50
Potential Upside/Downside
+13.8%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.60
Research Coverage
10 Analysts

Profitability

Net Income
$13.76 million
Pretax Margin
2.88%

Debt

Sales & Book Value

Annual Sales
$647.51 million
Cash Flow
$0.85 per share
Book Value
$12.12 per share

Miscellaneous

Free Float
229,162,000
Market Cap
$3.16 billion
Optionable
Optionable
Beta
1.16

Social Links

These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Key Executives

  • Mr. Richard K. Matros (Age 70)
    Chairman, President & CEO
    Comp: $2.52M
  • Mr. Michael Lourenco Costa (Age 45)
    Executive VP, CFO & Secretary
    Comp: $799.16k
  • Ms. Talya Nevo-Hacohen (Age 64)
    Executive VP, Chief Investment Officer & Treasurer
    Comp: $1.32M
  • Ms. Jessica Flores (Age 41)
    Executive VP, Chief Accounting Officer & Principal Accounting officer
  • Mr. Peter W. Nyland
    Executive Vice President of Asset Management
  • Mr. Darrin L. Smith
    Executive Vice President of Investments
  • Mr. Lukas Michael Hartwich C.F.A.
    Senior Vice President of Finance
  • Ms. Eliza Gozar
    Senior Vice President of Investments

SBRA Stock Analysis - Frequently Asked Questions

Should I buy or sell Sabra Health Care REIT stock right now?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sabra Health Care REIT in the last year. There are currently 4 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" SBRA shares.
View SBRA analyst ratings
or view top-rated stocks.

What is Sabra Health Care REIT's stock price target for 2024?

10 brokers have issued twelve-month price targets for Sabra Health Care REIT's stock. Their SBRA share price targets range from $12.50 to $21.00. On average, they expect the company's share price to reach $15.54 in the next year. This suggests a possible upside of 13.8% from the stock's current price.
View analysts price targets for SBRA
or view top-rated stocks among Wall Street analysts.

How have SBRA shares performed in 2024?

Sabra Health Care REIT's stock was trading at $14.27 at the start of the year. Since then, SBRA stock has decreased by 4.3% and is now trading at $13.66.
View the best growth stocks for 2024 here
.

When is Sabra Health Care REIT's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 1st 2024.
View our SBRA earnings forecast
.

How were Sabra Health Care REIT's earnings last quarter?

Sabra Health Care REIT, Inc. (NASDAQ:SBRA) released its quarterly earnings data on Wednesday, May, 4th. The real estate investment trust reported $0.18 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.17 by $0.01. Sabra Health Care REIT had a net margin of 2.12% and a trailing twelve-month return on equity of 0.47%. During the same period last year, the business posted $0.39 EPS.

How often does Sabra Health Care REIT pay dividends? What is the dividend yield for Sabra Health Care REIT?

Sabra Health Care REIT announced a quarterly dividend on Thursday, February 1st. Shareholders of record on Tuesday, February 13th will be given a dividend of $0.30 per share on Thursday, February 29th. This represents a $1.20 annualized dividend and a yield of 8.78%. The ex-dividend date of this dividend is Monday, February 12th.
Read our dividend analysis for SBRA
.

Is Sabra Health Care REIT a good dividend stock?

Sabra Health Care REIT (NASDAQ:SBRA) pays an annual dividend of $1.20 per share and currently has a dividend yield of 8.78%. SBRA has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 2,400.00%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on EPS estimates, SBRA will have a dividend payout ratio of 83.33% in the coming year. This indicates that the company may not be able to sustain their current dividend.
Read our dividend analysis for SBRA.

What guidance has Sabra Health Care REIT issued on next quarter's earnings?

Sabra Health Care REIT updated its FY 2024 earnings guidance on Tuesday, February, 27th. The company provided earnings per share guidance of 1.390-1.430 for the period, compared to the consensus earnings per share estimate of 1.380. The company issued revenue guidance of -.

What other stocks do shareholders of Sabra Health Care REIT own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Sabra Health Care REIT investors own include AT&T (T), Omega Healthcare Investors (OHI), Realty Income (O), Medical Properties Trust (MPW), Energy Transfer (ET), Verizon Communications (VZ), Bank of America (BAC), Annaly Capital Management (NLY), Ventas (VTR) and New Residential Investment (NRZ).

Who are Sabra Health Care REIT's major shareholders?

Sabra Health Care REIT's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Sumitomo Mitsui Trust Holdings Inc. (0.11%), Pensionfund DSM Netherlands (0.07%), State of Alaska Department of Revenue (0.06%), Arden Trust Co (0.05%), Pensionfund Sabic (0.03%) and State of Michigan Retirement System (0.02%). Insiders that own company stock include Catherine Cusack, Harold W Jr Andrews and Michael Lourenco Costa.
View institutional ownership trends
.

How do I buy shares of Sabra Health Care REIT?

Shares of SBRA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:SBRA) was last updated on 4/21/2024 by MarketBeat.com Staff

From Our Partners